Furthermore, we detected the relative expression of MAGI2-AS3 in blood samples to assess its role in PCa; the results showed that the MAGI2-AS3 mRNA concentrations were notably reduced in PCa patients than in BPH (Figure 8J). Here, MAGI2 is linked to benign prostatic hyperplasia.